Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) – From Preclinical Studies to a Clinical Phase II Trial

Heat shock protein 70 (Hsp70) is frequently overexpressed in tumor cells. An unusual cell surface localization could be demonstrated on a large variety of solid tumors including lung, colorectal, breast, squamous cell carcinomas of the head and neck, prostate and pancreatic carcinomas, glioblastomas...

Descripción completa

Detalles Bibliográficos
Autores principales: Specht, Hanno M., Ahrens, Norbert, Blankenstein, Christiane, Duell, Thomas, Fietkau, Rainer, Gaipl, Udo S., Günther, Christine, Gunther, Sophie, Habl, Gregor, Hautmann, Hubert, Hautmann, Matthias, Huber, Rudolf Maria, Molls, Michael, Offner, Robert, Rödel, Claus, Rödel, Franz, Schütz, Martin, Combs, Stephanie E., Multhoff, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397864/
https://www.ncbi.nlm.nih.gov/pubmed/25926832
http://dx.doi.org/10.3389/fimmu.2015.00162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397864/
https://www.ncbi.nlm.nih.gov/pubmed/25926832
http://dx.doi.org/10.3389/fimmu.2015.00162

Ejemplares similares